★ Sign in to follow
IB

IDL Biotech AB Stock: price and insider trades · Sweden

ISIN SE0000514747SE·

No insider purchase over the last 90 days. The latest, by Max Pihlqvist, was filed 28 Nov 2018.

IDL Biotech AB: what insiders have been doing

Every trade that managers of IDL Biotech AB disclose to Finansinspektionen is tracked on this page. The past year has been quiet: not a single insider filing for IDL Biotech AB. The previous disclosure was published on 17 June 2019.

Over the whole record (from 2018), the tally stands at 7 purchases and 1 sale.

Other companies in the same market with recent insider buying flagged by our signals: Dynavox Group AB and Rusta AB (publ). Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.

Insider Decl.
10
Thresholds
n/a
Buy Volume
€49,983
7 ops. · all time
Sell Volume
€1M
1 ops. · all time

Financial data

· cache

Last declaration on 17 June 2019
Declarations10 total
  • ●
    Jerker Swanstein
    Styrelseledamot/suppleantExecutives
    351,736 SEK15FI-SE
    140,000 shares@ SEK 2.5124100.0% of flowAktieISIN SE0000514747FI:csv-ef7a0f1f50bcd7944a81
  • ●
    Max Pihlqvist
    Styrelseledamot/suppleantExecutives
    3M SEK9FI-SE
    2,916,666 shares@ SEK 1.2018.9% of flowAktieISIN SE0000514747FI:csv-11138c556480f083bc05
  • ▼
    Max Pihlqvist
    Styrelseledamot/suppleantExecutives
    15M SEK15FI-SE
    5,500,000 shares@ SEK 2.7080.7% of flowAktieISIN SE0000514747FI:csv-4e1b6e2f5f07cb47b3a9
  • ▲
    Max Pihlqvist
    Styrelseledamot/suppleantExecutives
    76,320 SEK0FI-SE
    63,600 shares@ SEK 1.200.4% of flowBTA (betald tecknad aktie)ISIN SE0011896356FI:csv-a5a4d5adb1ad2fb0eaee
    Canonical exit: 25 Feb 2019 (T+90)
  • ▲
    Bo Gunnar Carsten Olsson
    Styrelseledamot/suppleantExecutives
    84,240 SEK0FI-SE
    70,200 shares@ SEK 1.20100.0% of flowBTA (betald tecknad aktie)ISIN SE0011896356FI:csv-fc6e93c5f1392b328dab
    Canonical exit: 25 Feb 2019 (T+90)
  • ▲
    Ingan Marie Torstensson
    MarknadschefExecutives
    72,000 SEK0FI-SE
    60,000 shares@ SEK 1.20100.0% of flowBTA (betald tecknad aktie)ISIN SE0011896356FI:csv-01d93fdb802931e01011
    Canonical exit: 25 Feb 2019 (T+90)
  • ▲
    Per-Anders Abrahamsson
    Styrelseledamot/suppleantExecutives
    59,760 SEK0FI-SE
    49,800 shares@ SEK 1.20100.0% of flowBTA (betald tecknad aktie)ISIN SE0011896356FI:csv-7b75e3614334092ba9b2
    Canonical exit: 25 Feb 2019 (T+90)
  • ▲
    Lars Jakobsson
    Ekonomi/finanschefExecutives
    52,560 SEK0FI-SE
    43,800 shares@ SEK 1.20100.0% of flowBTA (betald tecknad aktie)ISIN SE0011896356FI:csv-c866358d680c7108c7db
    Canonical exit: 25 Feb 2019 (T+90)
  • ▲
    Charlotte Berg
    VDExecutives
    86,400 SEK0FI-SE
    72,000 shares@ SEK 1.20100.0% of flowBTA (betald tecknad aktie)ISIN SE0011896356FI:csv-95c57532f624b6003799
    Canonical exit: 25 Feb 2019 (T+90)
  • ▲
    Labbex Förvaltnings AB
    Related company / holdingExecutives
    84,500 SEK15FI-SE
    25,000 shares@ SEK 3.38100.0% of flowAktieISIN SE0000514747FI:csv-76956d1301cb799623e0
    Canonical exit: 1 Jan 2019 (T+90)

10 of 10 declarations

About IDL Biotech AB

IDL Biotech AB is a company focused on developing diagnostic solutions for the healthcare sector. It is listed on the Stockholm Stock Exchange (XSTO).

Recent ranked signals on the same market

Purchases our model currently ranks for the recommendations list.

All recommendations

Related companies and executives

No related entities found.